Early infiltrating NKT lymphocytes attenuate bone regeneration through secretion of CXCL2.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38758783.
- Also identified by DOI 10.1126/sciadv.adl6343 and PMC identifier 11100573.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Trauma rapidly mobilizes the immune response of surrounding tissues and activates regeneration program. Manipulating immune response to promote tissue regeneration shows a broad application prospect. However, the understanding of bone healing dynamics at cellular level remains limited. Here, we characterize the landscape of immune cells after alveolar bone injury and reveal a pivotal role of infiltrating natural killer T (NKT) cells. We observe a rapid increase in NKT cells after injury, which inhibit osteogenic differentiation of mesenchymal stem cells (MSCs) and impair alveolar bone healing. <i>Cxcl2</i> is up-regulated in NKT cells after injury. Systemic administration of CXCL2-neutralizing antibody or genetic deletion of <i>Cxcl2</i> improves the bone healing process. In addition, we fabricate a gelatin-based porous hydrogel to deliver NK1.1 depletion antibody, which successfully promotes alveolar bone healing. In summary, our study highlights the importance of NKT cells in the early stage of bone healing and provides a potential therapeutic strategy for accelerating bone regeneration.
Medical subject headings
- Bone Regeneration
- Chemokine CXCL2
- Natural Killer T-Cells
- Osteogenesis